← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2016Last known activity
Oct 22, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT07251413Lead sponsorPhase 1/Phase 2Oct 22, 2025
- NCT04772235Study chairPhase 1Apr 30, 2021
- NCT04772235Lead sponsorPhase 1Apr 30, 2021
- NCT04537130Lead sponsorPhase 1Dec 1, 2020
- NCT04487756Lead sponsorPhase 1/Phase 2Oct 31, 2020
- NCT03623750Study directorPhase 1/Phase 2Jul 6, 2018
- NCT03623750Study chairPhase 1/Phase 2Jul 6, 2018
- NCT03623750Lead sponsorPhase 1/Phase 2Jul 6, 2018
- NCT02841579Overall official - principal investigatorPhase 2Aug 1, 2016
Details
- Last known activity
- Oct 22, 2025